Scientist and leader @rhoworld working on neuroscience and NIH studies. Opinions are my own. NIAID U01 PI.
USA
Joined January 2008
- Tweets4.7K
- Following817
- Followers894
- Likes2.3K
This study was super complex and so much credit is due the operational team who got it done. There are 3 complex stages, multiple randomizations, and 95 secondary outcomes. classic.clinicaltrials.gov/c…
I'm very excited that the OUtMATCH study, run by my team under awards from NIAID, was central to the FDA's approval of omalizumab to treat food allergy. This is a huge win for everyone worried about accidental exposures to allergens. fda.gov/news-events/press-an…
Great interview with Karl Kieburtz on the promise of CVN424 to provide relief and hope to people with Parkinson's. youtube.com/watch?v=0CBl0IpV…
Peter Schmidt retweeted
Only three applications submitted so far! If you live in Ward 3, please consider applying by 5pm today!!
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
People who are interested in this innovative Parkinson's trial should check out the trial website: ascendclinicaltrial.com/
It lists the inclusion criteria and a pre-screener.
A @DavisPhinneyFND blog on a new trial just posted. Of the two neural circuits we focus on in Parkinson's, the "direct" and "indirect" pathways, most drugs target the direct pathway. DBS targets the indirect. This drug could also help the indirect pathway. davisphinneyfoundation.org/c…
This trial is currently recruiting! It would be great to get participants in Detroit, Scottsdale, Southern Illinois, Memphis, Boulder, and several sites across south Florida. Check the site listing here: clinicaltrials.gov/study/NCT…
A @DavisPhinneyFND blog on a new trial just posted. Of the two neural circuits we focus on in Parkinson's, the "direct" and "indirect" pathways, most drugs target the direct pathway. DBS targets the indirect. This drug could also help the indirect pathway. davisphinneyfoundation.org/c…
If you are interested in Parkinson’s, @MichaelOkun’s interview here with @SoaniaMathur shows why his perspective is the best there is in the field. Great for scientists, clinicians and patients alike. davisphinneyfoundation.org/p…
We need better, more straightforward guidance on diagnosis and management, too. New drug formulations could help.
We as a community need to reach and train more general medical professionals to help with the growing number of movement disorders patients.
Share this across your networks: loom.ly/uN98F3g
Very proud of @HuntingtonSG! Two HSG trials were recognized in the #MDSCongress highlights session. One of the drugs was approved.
Scandinavian metalwork changed battle wounds: a human skull with sword or axe wound, from the Viking era. National Museum of Ireland - Archaeology, Dublin. Undated. Cc @OGdukeneurosurg
Great #wpc2023 conference with all my Parkinson’s friends. I visited with @ParkinsonDotOrg’s leading light in professional education, Denise, and Gila Bronner, sex therapist extraordinaire.
